16.12

2.84% -0.4474

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $16.12, with a volume of 97,579. It is down -2.84% in the last 24 hours and down -15.04% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Previous Close:

$16.57

Open:

$16.6

24h Volume:

97,579

Relative Volume:

0.39

Market Cap:

$506.82M

Revenue:

$290.71M

Net Income/Loss:

$-163.43M

P/E Ratio:

-2.9421

EPS:

-5.48

Net Cash Flow:

$11.70M

1W Performance:

-3.25%

1M Performance:

-15.04%

6M Performance:

-31.52%

1Y Performance:

-36.16%

1-Day Range:

$16.01

$16.73

1-Week Range:

$16.01

$17.00

52-Week Range:

$16.01

$26.36

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1187)

Industry

Diagnostics & Research (60)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,012

Twitter

@FulgentGenetics

Next Earnings Date

2024-11-08

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	16.11	506.82M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	568.24	219.06B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	206.88	151.02B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	145.19	42.12B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	457.80	37.71B	3.84B	866.24M	792.60M	10.37
IQV Iqvia Holdings Inc	207.19	36.97B	15.32B	1.41B	1.96B	7.62

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

12:29 PM

Fulgent Genetics (NASDAQ:FLGT) Hits New 52-Week LowHere's Why - MarketBeat

12:29 PM

Feb 06, 2025

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025 - The Bakersfield Californian

Feb 06, 2025

Feb 04, 2025

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics - Business Wire

Feb 04, 2025

Feb 03, 2025

Fulgent Genetics stock hits 52-week low at $16.54 By Investing.com - Investing.com Canada

Jan 23, 2025

Jan 15, 2025

Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet? - Simply Wall St

Jan 15, 2025

JPMorgan Chase & Co. Raises Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jan 15, 2025

GAMMA Investing LLC Has $39,000 Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jan 15, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Acquired by JPMorgan Chase & Co. - MarketBeat

Jan 15, 2025

When the Price of (FLGT) Talks, People Listen - Stock Traders Daily

Jan 15, 2025

Jan 14, 2025